Primary central nervous system and brain tumors are one of the global burdens that are
continuously increasing in cases and requiring more treatment options. Surgery has been …

Background Atypical meningiomas are common central nervous system neoplasms with
high recurrence rate and poorer prognosis compared to their grade I counterparts. Surgical …

Background Patients with glioblastoma (GBM) have a dismal prognosis, and there is an
unmet need for new therapeutic options. This study aims to identify new therapeutic targets …

Brain tumors, whether primary or secondary, have limited information about proteomic
changes despite advances in understanding the driver gene mutation and heterogeneity …

The manifestation of intra-and inter-tumor heterogeneity hinders the development of
ubiquitous cancer treatments, thus requiring a tailored therapy for each cancer type …

Neuroblastoma is the most common malignant tumor in childhood, and metastases occur in
more than 30% patients. Recurrent metastasis is the main cause of poor prognosis and high …

Simple Summary The most prevalent and lethal primary brain tumor, glioblastoma
multiforme (GBM), exhibits fast growth and widespread invasion and has a poor prognosis …

2018 Background: Glioblastoma (GBM), the most common primary brain tumor in adults,
universally recurs and has a dismal prognosis. Therefore, there is an unmet need for new …

Finding better therapies for the treatment of brain tumors is hampered by the lack of
consistently obtained molecular data in a large sample set and the ability to integrate …

Glioblastoma multiforme (GBM), the most aggressive and lethal primary brain tumor, is
characterized by very low life expectancy. Understanding the genomic and proteogenomic …